Kelato Animal Health Company Profile

Background

Company Overview

Kelato Animal Health, established in 1988 as Chelated Laboratories Pty Ltd in Melbourne, Australia, is a company dedicated to enhancing equine health and performance through innovative nutritional and healthcare products. In November 2004, the company was acquired by Evolution Animal Health Pty Ltd and relocated to Sydney in January 2005. Kelato has developed an international reputation for quality and innovation, focusing on producing a range of horse health and nutrition products that help horses feel well so they perform well.

Mission and Vision

Kelato's mission is to ensure all horses feel well, operating under the belief that a horse's well-being directly influences its performance. The company is committed to providing products that are unique, value for money, and deliver genuine, worthwhile results for customers.

Key Strategic Focus

Core Objectives and Specialization

Kelato specializes in equine health and nutrition, offering a range of products designed to maximize horse condition, performance, and general well-being. The company's core objectives include developing innovative products that bridge the gap between nutrition and pharmaceuticals, enhancing animal health, and increasing performance and production parameters.

Key Technologies and Markets

Kelato utilizes research-driven approaches and has formed alliances with other animal health companies to trial new combinations of compounds that produce real and measurable results. The company focuses on utilizing effective compounds that are sustainable or environmentally compatible. Kelato's products are marketed to a diverse customer base, including elite racing stables, top-level three-day eventers, dressage riders, and pony clubbers.

Financials and Funding

Revenue and Employees

As of the latest available data, Kelato Animal Health reports an annual revenue of approximately $4.1 million and employs 19 individuals.

Pipeline Development

Product Range

Kelato offers a variety of equine health products, including:

BetaMARE: A supplement designed to support mares' behavioral balance.

GastroAID Everyday: A daily supplement aimed at maintaining optimal gut health.

GastroAID Recovery: Formulated to assist in the recovery from gastric ulcers and support overall digestive health.

SwellDOWN: A clay poultice used to reduce swelling and inflammation in horses.

These products are part of Kelato's commitment to providing quality and innovative nutritional, nutraceutical, and healthcare products that enhance the health and well-being of horses.

Technological Platform and Innovation

Proprietary Technologies

Kelato's product development is research-driven, focusing on innovative formulations that address specific equine health issues. The company has developed products like PROTEK GI, which targets both foregut and hindgut health by providing coating agents that form an alkaline slime barrier over the stomach wall to help protect against acid burn while buffering gastric acid and strengthening the mucosal lining. This product also includes Levucell SC® yeast probiotic and Agrimos® yeast prebiotic to support hindgut health.

Scientific Methodologies

Kelato collaborates with leading equine veterinarians and nutritionists to ensure that information supporting their products reflects the latest in equine knowledge and practice. The company is committed to utilizing compounds that are sustainable or environmentally compatible.

Leadership Team

Key Executives

Suzanne Clark: National Sales Manager, responsible for overseeing sales operations and managing territory managers across various regions.

Natalia Budisa BAnVetBioSc (Hons): Technical and Product Coordinator, focusing on product development and technical support.

Claire Bridgewater: Brand and Communications Manager, responsible for managing the company's brand image and communication strategies.

Expert Affiliations

Dr. Ben Sykes BSc BVMS MS MBA DipACVIM PhD: A leading equine veterinarian specializing in Equine Gastric Ulcer Syndrome (EGUS), collaborating with Kelato on research and development.

Dr. David Ward BVMS BScAgr MScVS Grad.Dip.Vet.Acup.CCRP: An integrative veterinary physician partnering with Kelato to deliver integrative veterinary care backed by science.

Competitor Profile

Market Insights and Dynamics

The global animal health market was valued at USD 58.28 billion in 2022 and is projected to grow to USD 117.48 billion by 2031, at a CAGR of 8.1%. This growth is driven by increasing pet adoption, rising prevalence of zoonotic diseases, and advancements in animal healthcare technologies.

Competitor Analysis

Kelato operates in a competitive landscape alongside companies such as: